Company Information

1. Name

ISU Abxis

2. Website Address

http://www.abxis.com/eng_new/main.asp

3. Location

Global B&D Center, Bldg.C 5th FI., 22, Daewangpangyo-ro 712beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do,463-000, Korea

4. Contacts

Juneyoung Park, PhD., VP Business Planning & Development

Phone: +82-31-696-4620

E-mail: jpark@isu.co.kr

5. References

-

Pharmaceutical Product Information

Clotinab (Abciximab)

1. Name

Clotinab

3. Indication

Adjunct to Percutaneous Coronary Intervention (PCI)

4. Information

The first therapeutic antibody developed in Korea and the world’s second Abciximab

Launched in Korea in 2007 and exported to twelve countries including India, Turkey, Columbia, Venezuela and etc.

5. Images

Abcertin (Imiglucerase)

1. Name

Abcertin

3. Indication

Enzyme Replacement Therapy (ERT) for Gaucher disease (GD)

4. Information

Launcher in Korea in 2013 and under the registration in around 20 countries